Skip to content

Clinical application of esketamine in intravenous analgesia for primipara after cesarean section

Clinical application of esketamine in intravenous analgesia for primipara after cesarean section

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100047419
Enrollment
Unknown
Registered
2021-06-18
Start date
2021-07-01
Completion date
Unknown
Last updated
2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esketamine

Interventions

Control group:Dezocine
Experimental group:Esketamine

Sponsors

The First Pepole's Hospital of Huaihua
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1.Aged 20 to 40 years, primipara; 2.ASA <= II level; 3.Pregnancy greater than 28 weeks; 4.Height 150cm-170cm; 5.Weight 50kg-100kg; 6.No serious cardiovascular and cerebrovascular diseases; 7.The parturient can communicate well with the follower; 8.Volunteer to participate in this research and sign the relevant informed consent; 9.Voluntarily accept postoperative intravenous analgesia and plan to undergo cesarean section patients under combined spinal-epidural anesthesia.

Exclusion criteria

Exclusion criteria: 1.Hypertension, diabetes; 2.Allergic to dexmedetomidine and sufentanil; 3.Have a history of cesarean section surgery; 4.Premature rupture of membranes, placenta previa, eclampsia, etc.; 5.Long-term use of sedatives, hypnotics, opioids, and psychotropic drugs; 6.HELLP syndrome; 7.Pregnancy-induced hypertension syndrome; 8.Patients change the method of anesthesia during the operation.

Design outcomes

Primary

MeasureTime frame
Vital signs;Analgesia score;Sedation score;Sleep quality;Edinburgh score;

Secondary

MeasureTime frame
Adverse reactions;

Countries

China

Contacts

Public ContactGuo Peng

The First Pepole's Hospital of Huaihua

11122961@qq.com+86 13787508238

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026